The American Society of Clinical Oncology (ASCO) recognized two Dana-Farber Cancer Institute researchers as winners of ASCO's Special Awards, the Society’s highest honors. The recipients of these awards have worked to transform cancer care around the world.
Among the recipients:
Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award
Jennifer A. Ligibel, MD is the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and the Director of the Center for Faculty Well-Being at Dana-Farber Cancer Institute, as well as an Associate Professor of Medicine at Harvard Medical School. Dr. Ligibel has dedicated her career to studying the role of exercise and weight management in the prevention and treatment of breast cancer and is a senior physician at the Susan F. Smith Center for Women's Cancer at Dana-Farber. The Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award honors Dr. Ligibel as an extraordinary female leader in oncology and a role model. The award recognizes outstanding female oncologists committed to the advancement of women in research and education with the goal of narrowing career gender disparities in oncology.
Walther Cancer Foundation Palliative and Supportive Care in Oncology Endowed Award and Lecture
Tracy A. Balboni, MD, MPH, FAAHPM is a radiation oncologist at Dana-Farber/Brigham and Women's Cancer Center and a Professor of Radiation Oncology at Harvard Medical School. Dr. Balboni has dedicated her career to palliative oncology care, including researching the psychosocial aspects of advanced cancer and radiotherapy for palliation, as well as examining the role of spirituality in the cancer journey, particularly in end-of-life treatment. The Walther Cancer Foundation Palliative and Supportive Care in Oncology Endowed Award and Lecture recognizes Dr. Balboni as a distinguished leader in palliative and supportive oncology through the prevention, assessment, and management of cancer- and treatment-related suffering.
ASCO will recognize their achievements at the ASCO 2021 annual meeting, held virtually June 4-8.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. We provide the latest treatments in cancer for adults through Dana-Farber/Brigham and Women’s Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 10 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.
As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.
# # #